TRUST BOARD DELIVERING EXCELLENCE: UPDATE ON THE TRUST S INTEGRATED MEDIUM TERM PLAN

Transcription

1 TRUST BOARD DELIVERING EXCELLENCE: UPDATE ON THE TRUST S INTEGRATED MEDIUM TERM PLAN Meeting Date: 13 th July 2017 Author: Sponsoring Executive Director: Report Presented by: Committee/Group who have received or considered this paper: Jeff O Sullivan Associate Director of Planning & Performance Carl James Director of Planning, Performance & Estates Carl James Director of Planning, Performance & Estates None Trust Resolution to: (please tick) Approve: Endorse: Discuss: Note: Recommendation: The Board is asked to NOTE the update report and appendix 1. This report supports the following Trust objectives as set out in the Integrated Medium Term Plan: (please tick) Equitable and timely services Providing evidence based care and research which is clinically effective Supporting our staff to excel Safe and reliable services First class patient /donor experience Spending every pound well

2 2 DELIVERING EXCELLENCE: UPDATE ON THE TRUST S INTEGRATED MEDIUM TERM PLAN 1. Introduction / Background: 1.1. The purpose of this paper is to update the Trust Board on the approval process to which Delivering Excellence, the Trust s Integrated Medium Term Plan (IMTP) for the period , has been subject. 2. Timing: 2.1. The Cabinet Secretary for Health, Well-being and Sport issued a written statement on 15 th June 2017, outlining the approval process and indicating the outcome of that process. Subsequently, the Trust received correspondence from Welsh Government on 16 th June 2017 which confirmed that Delivering Excellence, the Trust s IMTP had been approved. This correspondence is attached to this paper as appendix Description: 3.1. Delivering Excellence, the Trust s IMTP for the period has been approved Welsh Government (WG) officials will write to the Trust s Chief Executive in due course outlining the conditions and expectations for your Health Board (sic.) around key deliverables for year one of the plan and, if requested and approved, the terms of any adjustments to the resource allocation. At the time of writing, the Trust has not yet received this further correspondence. 4. Financial Impact 4.1. Approval of the IMTP and work associated with delivering improved performance supports sound financial governance across the Trust Negotiations between the Trust and commissioners focused on various funding issues on which the delivery of the IMTP is dependent are ongoing. If this funding cannot be secured, there is a risk that objectives described in the IMTP may not be attainable. The funding assumptions and ongoing negotiations have been explicitly highlighted to Health Boards and Welsh Government during the development of the IMTP and following submission of the IMTP. 5. Quality, Equality, Safety and Patient Experience Impact: 5.1. The approved plan has as its core the continued need for improved quality, equality, safety and patient / donor experience. Any additional national or local priorities that emerge during the year will need to be fed into our ongoing planning cycle and addressed as part of our operational, service and quality improvement processes. 6. Considerations for Board: 6.1. The Trust Board is asked to NOTE the approval of the IMTP and the contents of appendix Next Steps: Page 2

3 3 DELIVERING EXCELLENCE: UPDATE ON THE TRUST S INTEGRATED MEDIUM TERM PLAN 7.1. To continue the development of the next iteration of the Trust s IMTP for the period in anticipation of its submission to the WG for scrutiny in March Page 3

4

5

6 June RESEARCH & DEVELOPMENT COMMITTEE HIGHLIGHT REPORT FROM THE CHAIR OF THE RESEARCH & DEVELOPMENT COMMITTEE Meeting Date: 13 th July 2017 Author: Sponsoring Executive Director: Report Presented by: Sarah Townsend Professor Peter Barrett-Lee Professor Jane Hopkinson Trust Resolution to: (please tick) Approve: REVIEW: INFORM: ASSURE: Recommendation: The Committee are requested to receive the highlight report of the Trust R&D Committee of 29 th P 2017 and note the actions being taken. This report supports the following Trust objectives as set out in the Integrated Medium Term Plan: (please tick) Equitable and timely services Providing evidence based care and research which is clinically effective Supporting our staff to excel Safe and reliable services First class patient /donor experience Spending every pound well ACRONYMS R&D WCRC VCC Research & Development Wales Cancer Research Centre Velindre Cancer Centre

7 2 Highlight Report Executive Summary: This paper had been prepared to provide the Board with details of the key issues considered by the R&D Committee at its meeting on the 29 th June The Board is requested to NOTE the contents of the report and actions being taken. Key highlights from the meeting are reported below: ALERT/ ESCALATE R&D Activity Report A summary of the Welsh Key Indicators for the period April 2016 March 2017 demonstrates a fall in recruitment activity. It was agreed that this issue would be placed on the R&D risk register for investigation. Data analysis will be carried out to identify causality. Sue Morgan noted that Jayne Elias would be pleased to support this activity. R&D Risk Register The process for reporting R&D related risk will be reviewed to ensure appropriate progress through the management structure prior to submission to the R&D Committee. The R&D Risk Register was discussed and it was agreed that the Executive Management Board will review the high level risks and consider the need for escalation onto the Trust Risk Register. ADVISE Page 2

8 3 Highlight Report ASSURE Moondance Programme Highlight Report The Committee was pleased to receive this report that demonstrates the level of governance in place with only minor revision to the format and content requested. A quarterly highlight report will be provided to the Committee. Page 3

9 4 Highlight Report INFORM R&D Risk Register It was noted that a process was required to ensure linkage between the Trust Register and R&D Risk Register. Sue Morgan will pick this up with Sarah Townsend out of Committee. Business Case There were no business cases presented to the Committee this quarter. Finance Update As requested last quarter, the report for the financial year to 31 st March 2017 was presented and discussed, as was a report of Month 1. It was noted that this reporting process continues to be work in progress. The Committee were satisfied with the content. A Secondment for six months for a Principal R&D Finance and Contracting Manager has been approved and is out to advert. Marie Curie Research Governance Marie Curie has approached Velindre NHS Trust as a preferred organisation to undertake their UK wide research governance service. Early negotiations are in progress. Co-Sponsorship with Cardiff University A model for co-sponsorship has been agreed between Velindre NHS Trust and Cardiff University to facilitate the opening of phase III of a Trust sponsored study (Pathos III) into Europe. It is intended that this model will be considered in the management of future studies. Working with the Clinical Research Facility (CRF) An agreed model for working has been established between Velindre NHS Trust, the CRF and Cardiff & Vale UHB to give patients access to a wider portfolio of early phase studies that would otherwise not be feasible. Newsworthy Items The Committee congratulated the following staff on their recent appointments. Richard Adams has been appointed as Director Centre for Trials Research Cancer Group John Staffurth has been appointed a Personal Chair from Cardiff University R&D Committee Review Programme Work is in progress to review the scope and activity of the R&D Committee to include revision of the Terms of Reference Page 4

10 5 Highlight Report Appendices Report History None The Research & Development Committee highlight report is a standing quarterly agenda item Page 5

11 PUBLIC TRUST BOARD HIGHLIGHT REPORT FROM THE CHAIR OF THE VELINDRE NHS TRUST AUDIT COMMITTEE FOR NHS WALES SHARED SERVICES PARTNERSHIP Meeting Date: Author: Sponsoring Executive Director: Report Presented by: th 11P P April 2017 Roxann Davies, Compliance Officer Andy Butler, Director of Finance & Corporate Services Andy Butler, Director of Finance & Corporate Services Trust Resolution to: (please tick) Approve: REVIEW: INFORM: ASSURE: Recommendation: This report supports the following Trust objectives as set out in the Integrated Medium Term Plan: (please tick) Equitable and timely services Providing evidence based care and research which is clinically effective Supporting our staff to excel Safe and reliable services First class patient /donor experience Spending every pound well ACRONYMS NWSSP NHS Wales Shared Services Partnership WAO Wales Audit Office WG Welsh Government SMT Senior Management Team

12 P April 2 Highlight Report Executive Summary: This paper has been prepared to provide the Board with details of the key issues considered by the Velindre NHS Trust Audit Committee for NHS Wales Shared Services Partnership, at its meeting on the th 11P The Board is requested to NOTE the contents of the report and actions being taken Key highlights from the meeting are reported below: ALERT/ ESCALATE No matters to alert/escalate. ADVISE No matters to advise. Update from Interim Audit Visit ASSURE It was advised that the majority of work had been completed and that report findings and issues would be presented to the July Audit Committee meeting, however, there were no significant issues to report. It was noted that an IT Report would be brought to the June Audit Committee meeting by a representative of WAO. Internal Audit Progress Update The Internal Audit Progress update was received. ASSURE An update was provided relating to the progress of Internal Audit against its annual plan of business and highlighted the completed, finalised and work in progress audit reports. It was noted that a Risk Management Advisory Workshop would take place on 27th April which would be fed back to the Audit Committee in June. The Committee was advised that Velindre had received a presentation on the audit tracker, developed using the software, Teammate, which generates reminders to owners of recommendations and reports in order to ensure they are followed up and that Velindre had expressed an interest in taking part as a second pilot, alongside Betsi Cadwaladr UHB. Denbigh Stores Audit ASSURE The Committee considered the Denbigh Stores Audit Report. The key findings and recommendations were highlighted and it was noted that a reasonable assurance had been provided. It was suggested that a follow-up report be prepared by Procurement on the stocktaking recommendation. Page 2

13 P April 3 Highlight Report ASSURE General Medical Services Contractor Payments Audit The Committee considered the General Medical Services Contractor Payments Audit Report. The key findings and minor recommendation was highlighted and it was noted that a substantial assurance had been provided. Risk Management Audit ASSURE The Committee considered the Risk Management Audit Report. The key findings and recommendations were highlighted and it was noted that a reasonable assurance had been provided. It was noted that a Risk Management Advisory Workshop was being held for the SMT on 27 April 2017 and that this subject takes the form of a standing item on each SMT agenda. WfIS ESR OH Bi-Directional Interface Audit ASSURE The Committee considered the WfIS ESR OH Bi-Directional Interface Audit Report. The key findings and recommendations were highlighted and it was noted that a reasonable assurance had been provided. It was noted that this project was commissioned twelve months ago and the project management software was forcing users to undertake projects and methodology in a consistent manner. It was advised that we should look back at the implementation of the project and ensure lessons are learnt in readiness for future projects. INFORM Draft Annual Governance Statement 2016/2017 The Draft Annual Governance Statement was presented to the Committee, for endorsement and it was advised that we had worked with Velindre to ensure this document was prepared in alignment. The Committee were asked to provide any feedback by th 24P Tracking of Audit Recommendations INFORM The Tracking of Audit Recommendation report was presented to the Committee, which summarised the audit report ratings, actions and current status. It was noted that 2 recommendations are overdue. It was advised that all high priority recommendations were taken to SMT on a monthly basis. NWSSP Corporate Risk Register INFORM The NWSSP Corporate Risk Register paper was presented to the Committee, which highlighted the three red risks. It was noted that following comment at a recent SMT meeting, the recruitment and retention of staff risk had been escalated from an amber rating to a red rating. The Committee was informed of the new risk that had been added in relation to the NHS Wales bursary scheme. It was advised that a project group would be set-up to ensure implementation occurred in a timely basis and that we are on course to deliver both on time and in budget. Page 3

14 4 Highlight Report Audit Committee Effectiveness Survey INFORM The Audit Committee Effectiveness Survey was RECEIVED. The Committee was advised that it had been developed based on a model used in the Audit Committee Handbook and that we had aligned with Velindre, to ensure its consistency. It was advised that the Survey would be issued electronically, using Surveyi and that the link would be circulated in due course, with responses being due during the beginning of May. The Committee noted that results and graphs would be presented at the June Audit Committee meeting. Appendices None Report History - Page 4